Breast advanced malignancies

Clinical trials for Breast advanced malignancies explained in plain language.

Never miss a new study

Get alerted when new Breast advanced malignancies trials appear

Sign up with your email to follow new studies for Breast advanced malignancies, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Can a targeted drug tame advanced HER2-Positive breast cancer?

Disease control Completed

This study looks at how well trastuzumab deruxtecan (T-DXd) works and how safe it is in women with HER2-positive metastatic breast cancer. The drug is given as an intravenous infusion every three weeks to patients who have already tried other anti-HER2 treatments. Researchers wil…

Matched conditions: BREAST ADVANCED MALIGNANCIES

Sponsor: Mansoura University • Aim: Disease control

Last updated Aug 23, 2026 00:00 UTC

Breast advanced malignancies

Get alerted when new Breast advanced malignancies trials appear

Can a targeted drug tame advanced HER2-Positive breast cancer?